Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (513)
|
Core Tip (563)
|
Full Article (HTML) (2066)
|
Figures (1-1) (378)
|
Full Article (PDF)-1204K (150)
|
Full Article with Cover (PDF)-11949K (125)
|
Full Article (XML)-236K (86)
|
Audio-1342K (6)
|
Peer-Review Report-230K (89)
|
Answering Reviewers-97K (77)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5818)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (539)
|
Core Tip (587)
|
Full Article (HTML) (1442)
|
Tables (1-1) (466)
|
Full Article (PDF)-358K (126)
|
Full Article with Cover (PDF)-11106K (140)
|
Full Article (XML)-54K (78)
|
Audio-1072K (9)
|
Peer-Review Report-236K (75)
|
Answering Reviewers-62K (68)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4833)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (603)
|
Core Tip (498)
|
Full Article (HTML) (4918)
|
Figures (1-2) (405)
|
Tables (1-5) (384)
|
Full Article (PDF)-1655K (228)
|
Full Article with Cover (PDF)-12399K (169)
|
Full Article (XML)-226K (82)
|
Audio-1259K (9)
|
Peer-Review Report-216K (85)
|
Answering Reviewers-145K (79)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (12)
|
Total Visits (8467)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (609)
|
Core Tip (529)
|
Full Article (HTML) (3272)
|
Figures (1-1) (404)
|
Full Article (PDF)-601K (232)
|
Full Article with Cover (PDF)-11346K (101)
|
Full Article (XML)-89K (86)
|
Audio-384K (5)
|
Peer-Review Report-180K (72)
|
Answering Reviewers-74K (75)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (6511)
|
Similar Articles (334)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (583)
|
Core Tip (520)
|
Article Highlights (553)
|
Full Article (HTML) (2090)
|
Figures (1-4) (364)
|
Tables (1-3) (359)
|
Full Article (PDF)-1672K (130)
|
Full Article with Cover (PDF)-12418K (127)
|
Full Article (XML)-173K (75)
|
Audio-467K (6)
|
Peer-Review Report-182K (69)
|
Answering Reviewers-71K (97)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6487)
|
Similar Articles (2003)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (563)
|
Core Tip (564)
|
Article Highlights (656)
|
Full Article (HTML) (1911)
|
Figures (1-3) (426)
|
Tables (1-2) (393)
|
Full Article (PDF)-1874K (123)
|
Full Article with Cover (PDF)-12619K (108)
|
Full Article (XML)-114K (77)
|
Audio-386K (11)
|
Peer-Review Report-233K (92)
|
Answering Reviewers-161K (81)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7356)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (490)
|
Core Tip (477)
|
Article Highlights (546)
|
Full Article (HTML) (1354)
|
Figures (1-4) (345)
|
Full Article (PDF)-5746K (119)
|
Full Article with Cover (PDF)-16492K (98)
|
Full Article (XML)-96K (76)
|
Audio-3997K (6)
|
Peer-Review Report-192K (70)
|
Answering Reviewers-146K (74)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4988)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (541)
|
Core Tip (522)
|
Article Highlights (553)
|
Full Article (HTML) (2382)
|
Figures (1-4) (352)
|
Tables (1-5) (367)
|
Full Article (PDF)-6006K (157)
|
Full Article with Cover (PDF)-16750K (120)
|
Full Article (XML)-200K (79)
|
Audio-376K (3)
|
Peer-Review Report-182K (87)
|
Answering Reviewers-60K (89)
|
Supplementary Material-355K (91)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8061)
|
Similar Articles (1855)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (494)
|
Core Tip (559)
|
Article Highlights (561)
|
Full Article (HTML) (1590)
|
Figures (1-4) (367)
|
Tables (1-4) (366)
|
Full Article (PDF)-5941K (121)
|
Full Article with Cover (PDF)-16687K (105)
|
Full Article (XML)-115K (72)
|
Audio-187K (9)
|
Peer-Review Report-215K (69)
|
Answering Reviewers-37K (80)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6499)
|
Similar Articles (2467)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (527)
|
Core Tip (520)
|
Full Article (HTML) (1289)
|
Figures (1-1) (437)
|
Full Article (PDF)-5068K (115)
|
Full Article with Cover (PDF)-15813K (102)
|
Full Article (XML)-63K (68)
|
Audio-811K (3)
|
Peer-Review Report-266K (80)
|
Answering Reviewers-225K (81)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5231)
|
Similar Articles (4253)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (521)
|
Core Tip (523)
|
Full Article (HTML) (1309)
|
Full Article (PDF)-325K (105)
|
Full Article with Cover (PDF)-11079K (91)
|
Full Article (XML)-24K (80)
|
Audio-243K (1)
|
Peer-Review Report-215K (58)
|
Answering Reviewers-19K (61)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3715)
|
Similar Articles (393)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open